Yutaka Ishida

Rapid attenuation of anti-SARS-CoV-2 antibody in patients with musculoskeletal diseases who reinitiated intensive immunosuppressive therapies after COVID-19.

S. Higa, A. Ogata, S. Kawada, 2021, Arthritis & rheumatology.

Rapid attenuation of anti–SARS–CoV‐2 antibodies in patients with musculoskeletal diseases in whom intensive immunosuppressive therapies were reinitiated after COVID‐19: comment on the article by Curtis et al

S. Higa, A. Ogata, S. Kawada, 2022, Arthritis & Rheumatology.